<?xml version="1.0" encoding="UTF-8"?>
<p id="par0145">Coagulopathy seems to be another issue that affects the prognosis in more severe cases. Importantly, elevated 
 <sc>d</sc>-dimer levels seem to be a marker to predict severe illness and mortality. Other laboratory findings like hrombocytopenia and prolonged prothrombin time also indicate a hyper-coagulation state in COVID-19 patients. The use of anticoagulant therapy has improved mortality rates in hospitalized patients with markedly elevated D-dimer or those who have sepsis-induced coagulopathy (SIC) score â‰¥4. With all the emerging evidence, current guidelines recommend a prophylactic dose of low molecular weight heparin (LMWH) for all hospitalized patients in the absence of contraindications [
 <xref rid="bib0250" ref-type="bibr">[50]</xref>, 
 <xref rid="bib0255" ref-type="bibr">[51]</xref>, 
 <xref rid="bib0260" ref-type="bibr">[52]</xref>]
</p>
